Ventyx Biosciences Inc (VTYX) PT Raised to $60 at Oppenheimer
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- US stock futures rise as investors assess Democrats' midterm sweep
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts VTYX Hot Sheet
Price: $14.00 --0%
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 17 | New: 12
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 17 | New: 12
Join SI Premium – FREE
Oppenheimer analyst Jeff Jones raised the price target on Ventyx Biosciences Inc (NASDAQ: VTYX) to $60.00 (from $55.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Neurocrine Bio. (NBIX) PT Raised to $224 at Guggenheim
- AtriCure Inc. (ATRC) PT Raised to $70 at Piper Sandler
- Duolingo Inc. (DUOL) PT Raised to $155 at Wedbush
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
